Navigation Links
L.A. City Attorney Rocky Delgadillo, Patient Activists to Unveil New Television Ad Targeting Health Insurers
Date:6/18/2008

Announcement Comes on Eve of Health Insurance Convention Expected to Draw

Thousands of Protestors to San Francisco Delgadillo to Discuss Legal Efforts to Crack Down on "Unlawful, Fraudulent,

and Unfair Business Acts and Practices" of Insurers

SAN FRANCISCO, June 18 /PRNewswire/ -- On the eve of a national day of protest against health insurance corporations, Los Angeles City Attorney Rocky Delgadillo will join a number of patients outside an insurance industry convention in San Francisco, today, June 18 to unveil a new television advertising campaign targeting the insurers and their denial of care.

The ads will launch Thursday, June 19, as thousands of people pour into the streets of San Francisco outside the insurance convention, and in 19 other cities across the country, to protest the insurers and to advocate for guaranteed healthcare, such as HR 676 and SB 840, the federal and state bills for an improved and expanded "Medicare for All."

WHAT: L.A. City Attorney Rocky Delgadillo, Patients Unveil Ad

Campaign Targeting Insurers

WHEN: Wednesday, June 18, 2:30 pm

WHERE: Outside Moscone West, 4th & Howard Streets, San Francisco,

California

Delgadillo has won national acclaim for his efforts to rein in insurance industry abuses, including:

-- Suing insurer Anthem Blue Cross of California for fraudulent business practices and deceptive advertising in the course of illegally rescinding 6,000 insurance policies

-- Suing insurer Health Net for engaging in unlawful and deceptive business practices that lead to denial of care claims.

-- Winning passage of a first-of-its-kind local ordinance to crack down on "patient dumping" by hospitals

The ad was produced by the Courage Campaign and funded by the California Nurses Association and Sen. Sheila Kuehl. Titled "Insurance Jive," it features a nurse explaining to a family that their care is
'/>"/>

SOURCE California Nurses Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Departments Efforts to Combat Healthcare Fraud Nationwide
2. Attorney General Michael B. Mukasey to Deliver Keynote Address at Naturalization Ceremony and Remarks on Nationwide Efforts to Combat Healthcare Fraud
3. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
4. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
5. Wage Complaint Forwarded to Attorney General for Prosecution
6. Consumer Watchdog Applauds L.A. City Attorneys Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage
7. Consumer Watchdog Applauds L.A. City Attorneys Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same
8. Pennsylvania Attorney General Corbett, American Lung Association & Others Call for New MSA Funds to Be Used for Tobacco Prevention and Cessation
9. Attorney Weight Loss Video to be Released by Leventhal Weight Loss Incorporated
10. Bikini Model to be Featured in Attorney Weight Loss Video
11. Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...e/ -- During a memorial service in the Capitol Ro...d Lieutenant Governor Catherine Baker Knoll as a l...rvice, and a tireless advocate for the people of P...d lieutenant governor, Catherine was a noted and s...r family and her faith were driving forces in her ...
(Date:11/21/2008).../ -- The Generic,Pharmaceutical Association (GPhA...A President and CEO Kathleen Jaeger regarding the ...rging Health Care Competition and Consumer Issues....ng this roundtable demonstrates the,growing momen...safe and,affordable biogenerics sooner rather tha...
(Date:11/21/2008)...e to combat cancer, study says, , , F...hers have discovered that some cancer cells use la...t lead to new treatments that starve and kill thes...s in the body need to produce energy. They do this...es oxygen. Compared with normal cells, tumor cells...
(Date:11/21/2008)...enter.com, the premier site,for online nursing co...been,updated to improve the interactive experienc...ppincott Williams & Wilkins (LWW), NursingCent...uing education activities and free,access to 11,0...nals.,Lippincott Williams & Wilkins is a part...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3
....S prescription use released last week revealed th...on// for Attention Deficiency Hyperactivity Disord...a similar prescription themselves. In the year 200...hildren and their parents were studied by research...
...versity study that used thermal imaging technology... rates has turned the conventional // wisdom that ...ead. “Comparing sexual arousal between men and wom...e in the amount of time it takes healthy young men...
...ry 523 children and adolescents in the United Stat...ding to estimates // from a major national study c...largest surveillance effort of diabetes among yout...n the United States, said Ronny A. Bell, Ph.D., M....
...rchers led by a team from the University of Virgin...hinovirus, // the cause of half of all colds, may ...ng an infectious gift for others who follow them. ... other forms of skin to skin contact can result in...
Other Medicine News:Health News:Thermal Imaging Shatters Arousal Gender Gap Myth 2Health News:One in 523 Children and Adolescents Have Diabetes 2Health News:One in 523 Children and Adolescents Have Diabetes 3Health News:Hotel Guests Often Leave Their Cold Behind 2
(Date:11/20/2008)...., Nov. 20 Radius Health ("Radius"... $15 million to its second institutional financing...2.5 million and the total amount raised since the ...g institutional investors participated in the fina...cluding MPM Capital, The Wellcome Trust, HealthCar...
(Date:11/19/2008)...Calif., Nov. 19 Amgen,(...gy Company, a subsidiary of,Takeda Pharmaceutical...,enrollment in the Phase 3 MONET1 trial evaluatin...xel and carboplatin for the first-line treatment o... been temporarily suspended,following a planned s...
(Date:11/19/2008)...llion Payment from Roche- , , MONTVALE, N.J...ceuticals Corp. (Nasdaq: MEMY ) today announced ...hase 2 trial of R3487/MEM 3454, its lead alpha-7 n... associated with schizophrenia (CIAS). The Compan..., triggering a $5.0 million payment from its partn...
(Date:11/18/2008)...ssociation,s 2008 Faces of Influenza survey unders...against influenza; Mother and Gold Medalist Kristi..., Nov. 18 While 78 percent of moth...re and potentially life-threatening disease that c... families will get vaccinated this season, accordi...
Breaking Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6InkSure and AuthentiForm Announce Assignment of Patent Portfolio 10261 1InkSure and AuthentiForm Announce Assignment of Patent Portfolio 10261 2InkSure and AuthentiForm Announce Assignment of Patent Portfolio 10261 3ActivBiotics Completes Sale of Fixed Assets 3B Expands Due Diligence Initiative for the Sale of Intellectual Property Including Drug Product Candidat 2778 1BioMarin Appoints Dr Gordon Vehar Vice President of Research 2777 1BioMarin Appoints Dr Gordon Vehar Vice President of Research 2777 2BioMarin Appoints Dr Gordon Vehar Vice President of Research 2777 3Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2776 1Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2776 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2776 3
...ESS WIRE)--May 8, 2007 - AVANIR,Pharmaceuticals (N...efficacy, safety and improvements in patient-cente...neuropathic (DPN) pain treated,with the investigat...e) will be presented in two scientific posters at ...ain, being held in,Berlin, Germany on June 7 to 10...
...RE)--May 9, 2007 - Results of a Phase 2a,clinical ...d,amikacin) to treat hospital acquired gram-negati...erican Thoracic Society (ATS),International Confer... Dr. Michael S. Niederman, MD, Chairman, Depar...Hospital, Professor of, Medicine; Vice C...
Other Medicine Technology:AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 4Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
Kaye Skin Hook, Single Prong
Designated most popular model or size.
Large deep curve.
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl
Medicine Products: